Erdheim-Chester disease diagnosed by 99mTc-MDP bone scintigraphy and brief literature review
1Department of Nuclear Medicine, Meram Faculty of Medicine, Necmettin Erbakan University, Faculty of Medicine, Department of Nuclear Medicine, 42080, Konya, Turkey. drozlemsahin@gmail.com.
Insights
Erdheim-Chester disease (ECD) is a rare histiocytosis. Diagnosis can be challenging, requiring specific immunohistochemical staining for definitive identification of histiocytes.
Area of Science:
- Histiocytosis and Cellular Biology
- Rare Diseases
- Diagnostic Pathology
Background:
- Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis characterized by lipid-laden macrophages and fibrosis.
- It is a multisystemic disorder with common sclerotic bone involvement, particularly in the distal femur and proximal/distal tibia.
Observation:
- A 40-year-old woman presented with systemic symptoms including knee pain, polyuria, and polydipsia over two years.
- Initial bone scintigraphy showed a "hot knee" pattern, leading to a femur biopsy for suspected hematologic malignancy, which revealed only intense fibrosis.
- A year later, bone scintigraphy displayed characteristic ECD bone involvement, and subsequent biopsies, initially showing fibrosis, confirmed histiocytes after CD-68 immunohistochemical staining.
Findings:
- Erdheim-Chester disease diagnosis was delayed due to initial biopsy findings.
- Immunohistochemical staining (CD-68) was crucial for identifying histiocytes, confirming the ECD diagnosis.
- The case highlights the diagnostic challenges associated with ECD, especially when initial pathological findings are non-specific.
Implications:
- This case underscores the importance of considering rare diseases like ECD in patients with suggestive systemic symptoms and bone findings.
- It emphasizes the critical role of advanced diagnostic techniques, such as immunohistochemistry, in confirming diagnoses that may be missed by standard histological examination.
- Early and accurate diagnosis of ECD is vital for appropriate management and improving patient outcomes.
Abstract:
Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis with lipid-laden macrophages and fibrosis. Although ECD is a multisystemic disease, the most common finding is sclerotic bone involvement in the diametaphyseal regions of bilateral distal femur and in proximal and distal tibia. We present a 40 years old woman who for the last two years had various systemic symptoms, especially knee pain, polyuria and polydipsia. Although a "hot knee" pattern was seen in bone scintigraphy (BS), a femur biopsy was performed, due to the preliminary diagnosis of haematologic malignancy. The biopsy specimen showed only intense fibrosis. One year later while the patient was in our clinic, BS showed characteristic for ECD bone involvement. Bone biopsy specimens stained in hematoxylin and eosin showed dense fibrosis but not histiocytosis. However, after immunohistochemical staining with CD-68, histiocytes were discerned. In conclusion, the authors underline that ECD was diagnosed at a second diagnostic attempt both clinically and by specific staining pathology specimens.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
06:16Author Spotlight: Establishing an Accurate Microhardness Testing Protocol for Craniofacial Tissues
Published on: April 26, 2024
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Diagnosing Acidosis and Alkalosis
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Bone Structure
Bone Remodeling
